Pharmacometrics is an interdisciplinary science with tremendous potential to influence decision making through the construction of mathematical and statistical models combined with graphical methods that define, challenge, and resolve queries surrounding the biological processes of a drug.
The November 2012 issue of APS contains one review and twelve original articles that focus on phase I trial design, phase I PK study, physiologically based PK modelling, PK/PD linking, population approach, dose finding, and stochastic simulation.
For more information please visit http://www.nature.com/aps/journal/v33/n11/index.html
(2012-11-6)